|
1
|
Rouzé A, Boddaert P, Martin-loeches I,
Povoa P, Rodriguez A, Ramdane N, Salluh J, Houard M and Nseir S:
Impact of chronic obstructive pulmonary disease on incidence,
microbiology and outcome of ventilator-associated lower respiratory
tract infections. Microorganisms. 8(165)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tsiligianni I, Metting E, Van Der Molen T,
Chavannes N and Kocks J: Morning and night symptoms in primary care
COPD patients: A cross-sectional and longitudinal study. An UNLOCK
study from the IPCRG. NPJ Prim Care Respir Med.
26(16040)2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tantucci C and Pini L: Inhaled
corticosteroids in COPD: Trying to make a long story short. Int J
Chron Obstruct Pulmon Dis. 15:821–829. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rabe KF, Hurd S, Anzueto A, Barnes PJ,
Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R,
van Weel C, et al: Global strategy for the diagnosis, management,
and prevention of chronic obstructive pulmonary disease: GOLD
executive summary. Am J Respir Crit Care Med. 176:532–555.
2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kallet RH: Ventilator bundles in
transition: From prevention of ventilator-associated pneumonia to
prevention of ventilator-associated events. Respir Care.
64:994–1006. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hellyer TP, Ewan V, Wilson P and Simpson
AJ: The Intensive Care Society recommended bundle of interventions
for the prevention of ventilator-associated pneumonia. J Intensive
Care Soc. 17:238–243. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Koulenti D, Parisella FR, Xu E, Lipman J
and Rello J: The relationship between ventilator-associated
pneumonia and chronic obstructive pulmonary disease: what is the
current evidence? Eur J Clin Microbiol Infect Dis. 38:637–647.
2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: PRISMA Group: Preferred reporting items for systematic reviews
and meta-analyses: The PRISMA Statement. PLoS Med.
6(e1000097)2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS,
Hahn S, Jang BH and Son HJ: Testing a tool for assessing the risk
of bias for nonrandomized studies showed moderate reliability and
promising validity. J Clin Epidemiol. 66:408–14. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wan X, Wang W, Liu J and Tong T:
Estimating the sample mean and standard deviation from the sample
size, median, range and/or interquartile. range.
14(135)2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Nseir S, Di Pompeo C, Soubrier S, Cavestri
B, Jozefowicz E, Saulnier F and Durocher A: Impact of
ventilator-associated pneumonia on outcome in patients with COPD.
Chest. 128:1650–1656. 2005.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Koulenti D, Blot S, Dulhunty JM, Papazian
L, Martin-Loeches I, Dimopoulos G, Brun-Buisson C, Nauwynck M,
Putensen C, Sole-Violan J, et al: COPD patients with
ventilator-associated pneumonia: Implications for management. Eur J
Clin Microbiol Infect Dis. 34:2403–2411. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Badawy MS, Omar HM, Mohamdien HA, Moktar
EA and Deaf EA: Evaluation of risk factors of ventilator associated
pneumonia on outcome of acute exacerbation of chronic obstructive
pulmonary disease. Egypt J Chest Dis Tuberc. 64:799–803. 2015.
|
|
14
|
Hadda V, Khilnani GC, Dubey G, Nallan R,
Kumar G and Guleria R: Impact of ventilator associated pneumonia on
outcome in patients with chronic obstructive pulmonary disease
exacerbation. Lung India. 31:4–8. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Rinaudo M, Ferrer M, Terraneo S, De Rosa
F, Peralta R, Fernández-Barat L, Li Bassi G and Torres A: Impact of
COPD in the outcome of ICU-Acquired pneumonia with and without
previous intubation. Chest. 147:1530–1538. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Makris D, Desrousseaux B, Zakynthinos E,
Durocher A and Nseir S: The impact of COPD on ICU mortality in
patients with ventilator-associated pneumonia. Respir Med.
105:1022–1029. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Celli BR and MacNee W: ATS/ERS Task Force:
Standards for the diagnosis and treatment of patients with COPD: A
summary of the ATS/ERS position paper. Eur Respir J. 23:932–946.
2004.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wu D, Wu C, Zhang S and Zhong Y: Risk
factors of ventilator-associated pneumonia in critically III
patients. Front Pharmacol. 10(482)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
van der Kooi TII, Boshuizen H, Wille JC,
de Greeff SC, van Dissel JT, Schoffelen AF and van Gaalen RD: Using
flexible methods to determine risk factors for
ventilator-associated pneumonia in the Netherlands. PLoS One.
14(e0218372)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rello J, Ausina V, Ricart M, Castella J
and Prats G: Impact of previous antimicrobial therapy on the
etiology and outcome of ventilator-associated pneumonia. Chest.
104:1230–1235. 1993.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Torres A, Aznar R, Gatell JM, Jiménez P,
González J, Ferrer A, Celis R and Rodriguez-Roisin R: Incidence,
risk, and prognosis factors of nosocomial pneumonia in mechanically
ventilated patients. Am Rev Respir Dis. 142:523–528.
1990.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ranzani OT, Ferrer M, Esperatti M, Giunta
V, Bassi GL, Carvalho CR and Torres A: Association between systemic
corticosteroids and outcomes of intensive care unit-acquired
pneumonia. Crit Care Med. 40:2552–2561. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Scott A, Wang X, Road J and Reid W:
Increased injury and intramuscular collagen of the diaphragm in
COPD: Autopsy observations. Eur Respir J. 27:51–59. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Rodríguez A, Lisboa T, Solé-Violán J,
Gómez F, Roca O, Trefler S, Gea J, Masclans JR and Rello J: Impact
of nonexacerbated COPD on mortality in critically Ill patients.
Chest. 139:1354–1360. 2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Moghoofei M, Azimzadeh Jamalkandi S, Moein
M, Salimian J and Ahmadi A: Bacterial infections in acute
exacerbation of chronic obstructive pulmonary disease: A systematic
review and meta-analysis. Infection. 48:19–35. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wu VKS, Fong C, Walters AM and Lele AV:
Prevalence, clinical characteristics, and outcomes related to
ventilator-associated events in neurocritically Ill patients.
Neurocrit Care. 33:499–507. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Melsen WG, Rovers MM, Groenwold RH,
Bergmans DC, Camus C, Bauer TT, Hanisch EW, Klarin B, Koeman M,
Krueger WA, et al: Attributable mortality of ventilator-associated
pneumonia: A meta-analysis of individual patient data from
randomised prevention studies. Lancet Infect Dis. 13:665–671.
2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kong CW and Wilkinson TM: Predicting and
preventing hospital readmission for exacerbations of COPD. ERJ Open
Res. 6:00325–02019. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Balasubramanian P and Tullu MS: Study of
ventilator-associated pneumonia in a pediatric intensive care Unit.
Indian J Pediatr. 81:1182–1186. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Karakuzu Z, Iscimen R, Akalin H, Girgin
NK, Kahveci F and Sinirtas M: Prognostic risk factors in
ventilator-associated pneumonia. Med Sci Monit. 24:1321–1328.
2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ranjan N, Chaudhary U, Chaudhry D and
Ranjan KP: Ventilator-associated pneumonia in a tertiary care
intensive care unit: Analysis of incidence, risk factors and
mortality. Indian J Crit Care Med. 18:200–204. 2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Crisafulli E, Barbeta E, Ielpo A and
Torres A: Management of severe acute exacerbations of COPD: An
updated narrative review. Multidiscip Respir Med.
13(36)2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Singanayagam A, Schembri S and Chalmers
JD: Predictors of mortality in hospitalized adults with acute
exacerbation of chronic obstructive pulmonary disease: A systematic
review and meta-analysis. Ann Am Thorac Soc. 10:81–89.
2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Recio Iglesias J, Díez-Manglano J, López
García F, Díaz Peromingo JA, Almagro P and Varela Aguilar JM:
Management of the COPD patient with comorbidities: An experts
recommendation document. Int J Chron Obstruct Pulmon Dis.
15:1015–1037. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Crawley A, Laubscher T, Muddiman P and
Kosar L: Pharmacologic management of COPD: Breadth of products for
encouraging a breath of air. Can Fam Physician. 62:410–414.
2016.PubMed/NCBI
|
|
36
|
Yamauchi Y, Yasunaga H, Hasegawa W,
Sakamoto Y, Takeshima H, Jo T, Matsui H, Fushimi K and Nagase T:
Effect of outpatient therapy with inhaled corticosteroids on
decreasing in-hospital mortality from pneumonia in patients with
COPD. Int J Chron Obstruct Pulmon Dis. 11:1403–1411.
2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Sibila O, Soto-Gomez N and Restrepo MI:
The risk and outcomes of pneumonia in patients on inhaled
corticosteroids. Pulm Pharmacol Ther. 32:130–136. 2015.PubMed/NCBI View Article : Google Scholar
|
